Pharmacovigilance
This page gives information on pharmacovigilance - the process by which we monitor the safety of medicines.
Black Triangle products
A black triangle is assigned to a product when it enters the market after clinical trials and we have relatively limited information about the medicine's safety.
Drug Analysis Prints (DAPs)
Drug Analysis Prints (DAPs) contain complete listings of all suspected adverse drug reactions or side effects, which have been reported by healthcare professionals and patients to the MHRA, via the Yellow Card Scheme .
The Yellow Card Scheme
This section gives details of The Yellow Card Scheme for reporting adverse drug reaction to medicines and vaccines.
Defective Medicines Report Centre
The MHRA’s Defective Medicines Report Centre (DMRC) plays a major part in the protection of public health by minimising the hazard to patients arising from the distribution of defective medicinal products.
